EUPRAXIA PHARMACEUTICALS INC. Repayments of Convertible Debt
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Repayments of Convertible Debt of $9.07 million for the 12-month period ending 2024-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-03-13
| Period end | Repayments of Convertible Debt 12 month |
|---|---|
| 2024-12-31 | $9.07M 40-F · filed 2026-03-13 |